In-Depth Notes on Shiga Toxin and Intestinal Tissue Response Study

Introduction to Shiga Toxin and Its Impact on Intestinal Function

  • Shiga toxin (Stx) is a critical virulence factor produced by pathogenic strains of Escherichia coli (E. coli), particularly O157:H7.
  • The toxin is associated with severe gastrointestinal diseases such as bloody diarrhea and hemolytic uremic syndrome (HUS).
  • This study focuses on understanding the effects of Stx2 on human intestinal tissue using human intestinal organoids (HIOs) and enteroids (HIEs).

Experimental Approach

  • Human Intestinal Organoids (HIOs) and Human Intestinal Enteroids Monolayers (HIEMs) were used to model human intestinal epithelial interactions.
  • HIEMs were created using mesenchymal cells in transwells to simulate epithelium-mesenchyme interactions.
  • Transepithelial electrical resistance (TEER) measurements were conducted to assess monolayer barrier integrity.
  • Saline was used on the apical surface to provide a more physiological environment for the epithelial cells.

Key Findings

  • Mesenchymal Cells in Epithelial Support:

  • Mesenchymal cells can maintain the barrier of epithelial monolayers even without added growth factors in the medium, indicating they produce essential growth factors.

  • Cell viability is affected negatively when growth factors are added to the medium, highlighting the toxicity of these supplements to mesenchymal cells.

  • Resistance to Shiga Toxin:

  • Epithelial cells exhibit a greater resistance to Stx2 compared to mesenchymal cells. Exposure to Stx2 lowers TEER values, indicating compromised barrier integrity.

  • Luminal exposure is better tolerated than basolateral exposure, suggesting different susceptibility mechanisms in epithelial cells.

  • Importance of Media and Growth Factors:

  • Frequent changes in medium (daily vs. every 3 days) affect the accumulation of growth factors necessary for maintaining barrier integrity. Daily changes reduce levels of protective factors from mesenchymal cells.

  • Use of apical saline instead of growth medium is essential for preserving the integrity of epithelial monolayers.

Mechanisms of Stx2 Action

  • Structure and Function:

  • Stx2 has an AB5 structure where the A subunit is active and the B subunit is responsible for receptor binding.

  • Upon binding to the receptor globotriaosylceramide (GB3), the toxin enters the cell and disrupts protein synthesis by cleaving rRNA in ribosomes.

  • Tissue-Specific Responses:

  • While the human intestinal barrier shows resilience to apical Stx2 exposure, basolateral exposure leads to rapid toxicity, mostly affecting mesenchymal tissues.

  • Studies indicate that transcytosis of Stx2 can occur across intact epithelial barriers without causing immediate damage to the epithelial layer.

Concluding Remarks

  • This research underscores the necessity of utilizing complex cell culture models to study human-specific responses to pathogens like STEC.
  • Mice, often used in modeling human infections, show resistance to infections that devastate human epithelial barriers, indicating species-specific variations in pathogenesis.
  • Understanding mesenchymal and epithelial interactions improves knowledge of disease progression and the development of therapeutic strategies against E. coli infections.